Buston v. Zoll Medical Corp.

31 Mass. L. Rptr. 479
CourtMassachusetts Superior Court
DecidedMarch 15, 2013
DocketNo. SUCV201201190
StatusPublished

This text of 31 Mass. L. Rptr. 479 (Buston v. Zoll Medical Corp.) is published on Counsel Stack Legal Research, covering Massachusetts Superior Court primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Buston v. Zoll Medical Corp., 31 Mass. L. Rptr. 479 (Mass. Ct. App. 2013).

Opinion

Kaplan, Mitchell H., J.

INTRODUCTION

This action arises out of Asahi Corporation’s (Asahi)2 acquisition of Zoll Medical Corporation (Zoll), a corporation organized under the laws of Massachusetts. On March 12, 2012, Zoll and Asahi jointly announced a definitive merger agreement (the Merger Agreement) pursuant to which Asahi would acquire the shares of Zoll through a cash tender offer (the Offer) followed by a short form merger of Zoll into an Asahi subsidiary. Shortly after the proposed merger was announced, four putative class action complaints were filed challenging the share price and the process that led to the Merger Agreement and the adequacy of Zoll’s disclosures concerning the Offer and contemplated merger.3 The plaintiffs are all holders of Zoll’s common stock and the defendants are Zoll and its directors, Asahi, and Asahi’s subsidiaries involved in the proposed Offer and merger. After discussions between the parties, the four actions were dismissed and refiled as a consolidated action in this court and then settled, subject to court approval, twenty-nine days after the first of the four actions was filed. More than ninety percent of the outstanding shares of Zoll were tendered, and the merger was completed in the manner contemplated in the Merger Agreement. On February 14, 2013, following notice to members of the class, a hearing was convened on the plaintiffs’ motion for the certification of a non-opt-out class—for settlement purposed only—and approval of the settlement. The defendants supported that motion. Plaintiffs and defendants did not, however, agree on an amount of attorneys fees that plaintiffs would ask the court to award plaintiffs’ counsel and Asahi to pay, nor did the defendants agree not to oppose plaintiffs’ fee request. The case is therefore before the court in the somewhat unusual posture, for this court, of a fully litigated attorneys fees request.

ADDITIONAL BACKGROUND

On March 26, 2012, Zoll filed its Schedulel4D-9 (the Schedule) with the Securities and Exchange Commission and made it available on its web site. The Schedule explained that Asahi was offering to purchase all of the outstanding shares of Zoll for $93 a share and that the Offer was scheduled to expire at the end of Friday, April 20, 2012, subject to a right to extend the Offer under certain circumstances and consistent with applicable law. $93 represented a premium of 29.6% over the weighted average closing price of Zoll’s stock during the 30 trading days preceding March 12, 2012, the day the Offer was announced. The Schedule also disclosed that, at a March 11, 2012 meeting, the Zoll Board of Directors (the Board) determined that the Offer and the related transactions were in the best interest of Zoll and its shareholders and authorized Zoll to enter into the Merger Agreement. The Schedule included as an attachment a letter to Zoll shareholders from defendant Richard Packer, Chief Executive Officer of Zoll, in which he advised shareholders that the Board unanimously recommended the Offer.

The Schedule described, among other things: the historic relationship that existed between Zoll and Asahi and the events and negotiations leading up to the execution of the Merger Agreement; the process that led to the Board’s selection of Brown Brothers Harriman & Co (BBH) as Zoll’s financial advisor and a description of BBH’s analysis of the fairness of the proposed transaction; and the Board’s consideration of whether initiating a competitive bidding process for Zoll was advisable under the circumstances; and the limited market-check approach that the Board directed BBH to conduct prior to concluding its negotiations with Asahi and signing the Merger Agreement.

On April 12, 2012, the defendants reached an agreement in principle with counsel to the plaintiffs to settle this consolidated action, subject to final approval by this court (the Settlement Agreement). The Settlement Agreement called for additional disclosures concerning: communications between Zoll and Asahi; BBH’s communications with three companies contacted by BBH to determine if they had any interest in acquiring Zoll; how BBN performed its discounted cash flow valuation of Zoll; and shareholders’ potential appraisal rights, if they rejected the Offer. These additional disclosures were set out in an amended Schedule filed with the SEC on April 13, 2012.

By the end of the initial Offer period, 20,916,921 shares had been tendered and not withdrawn. This represented 93.82% of the issued and outstanding shares; but included 3,088,887 tendered by notice of guaranteed delivery. The Offer was extended to April 25, 2012, by which date 20,745,382 shares were validly tendered (some of the guaranteed delivery shares were not ultimately tendered), which amounted to 93.05% of issued and outstanding shares. The merger was then completed in the manner contemplated by the Merger Agreement.

In addition to seeking certification of a class of Zoll shareholders for settlement purposes and approval of the settlement, plaintiffs have moved for an award of attorneys fees in the amount of $1,906,000. Plaintiffs break that sum down into two components: $450,000 for the additional disclosures set out in the amended [481]*481Schedule other than that relating to appraisal rights and $1,456,000 for Zoll’s concession regarding such rights.

DISCUSSION

The defendants do not contend that the plaintiffs’ attorneys efforts in this case provided no benefit to the Zoll shareholders, but maintain that the benefit was very modest and suggest that an award of $80,000 would be appropriate. Plaintiffs, in turn, submitted affidavits that collectively attest that the work performed by the six law firms that represented plaintiffs generated a lodestar of $381,207 and expenses of $25,859.50. Plaintiffs, however, assert that the result they achieved for the Zoll shareholders warrants a significant multiplier of the lodestar and request the award of fees and expenses noted above.

The plaintiffs argue at length that since the settlement provides for a broad release of all claims that the former Zoll shareholders might have against the defendants (and an extensive array of other associated “Released Parties”) relating to the Offer and the merger, the settlement must have provided great value to the class members—otherwise the settlement would be ’’illusory." Stated differently, the court understands this argument to be that the court could not find that the settlement was fair, adequate and reasonable to the members of the class without also implicitly finding that it was of sufficient benefit to support an award of substantial attorneys fees. The court does not find this argument convincing or consistent with the decisions of other Massachusetts Superior Courts or Delaware courts.

Weak claims asserted by shareholder plaintiffs in connection with corporate transactions of the kind at issue here, especially those in which discovery fails to identify significant facts that were not disclosed to shareholders, will give rise to modest awards of attorneys fees both in Massachusetts and Delaware courts. See, e.g., Massachusetts Superior Court cases Lorenzi v. Haydu, CA No. 09-4226-BLS1 (March 25, 2010), and Albright v. Leuchtenberger, CA No. 09-269-BLS2 (August 6, 2009), and Delaware cases cited in In re Sauer-Danfoss Inc. Shareholders Litigation, 2011 WL 2519210 at *15 (Del. Ch.) (May 3, 2011) (in which cases the Chancery Court awarded fees in the $80,000 range).

Free access — add to your briefcase to read the full text and ask questions with AI

Related

In re Sauer-Danfoss Inc. Shareholders Litigation
65 A.3d 1116 (Court of Chancery of Delaware, 2011)
Berman v. Linnane
434 Mass. 301 (Massachusetts Supreme Judicial Court, 2001)
In re Amicas, Inc. Shareholder Litigation
27 Mass. L. Rptr. 568 (Massachusetts Superior Court, 2010)

Cite This Page — Counsel Stack

Bluebook (online)
31 Mass. L. Rptr. 479, Counsel Stack Legal Research, https://law.counselstack.com/opinion/buston-v-zoll-medical-corp-masssuperct-2013.